May 20–22, 2025, EffePharm, a global leader in healthy aging and nutritional biotechnology, captivated attendees at Vitafoods Europe 2025 in Barcelona. Showcasing groundbreaking advancements in NAD+ research and nutrient delivery systems for improved dietary supplements, EffePharm solidified its position as a pioneer in scientifically validated anti-aging solutions. Here’s a deep dive into their latest breakthroughs and strategic vision. Revolutionizing NAD+ Supplementation EffePharm’s NAD+ Booster Series stole the spotlight, offering tangible solutions to age-related NAD+ supplementation—a key driver of cellular aging. What is NAD+? Read more UTHEVER® NMN: UTHEVER® NMN is the world's first clinically proven NMN brand. It is now positioned to become the first NMN ingredient to secure EU Novel Food certification. UTHEVER® is currently in the final review stage with the European Food Safety Authority (EFSA). Its impending approval paves the way for EU market entry, with multiple brands already securing pre-orders to capitalize on this regulatory milestone. Learn more about the NMN Novel Food Updates. UthPeak® NMNH (Reduced NMN): Backed by the world’s first double-blind human trial, UthPeak® demonstrated a 3x increase in NAD+ levels and a maximum 5-year reversal in biological age after 90 days of supplementation. Being EffePharm's premium NAD+ enhancer, its safety has already…

Join Effepharm at Booth 3G84 during Vitafoods Europe 2025 (May 20–22, Barcelona) to explore groundbreaking solutions that redefine healthy aging and nutrition absorption. Our team is eager to connect and share how our science-driven innovations can elevate your formulations and empower global wellness. Spotlight on Science: NAD Booster Line UthPeak® NMNH: The only Self-GRAS-approved NMNH with proven anti-aging results in 90 days. Longevity: Reverse biological age markers by up to 5 years* Energy & Mood: 35% boost in energy and 31% uplift in emotional well-being* NAD level increase: Up to 3X increase in NAD+ level* *Clinically validated in UthPeak® NMNH human trials (world's first clinical trial on reduced NMN). Learn More about the clinical study results. UTHEVER® NMN: Leading the EU Novel Food race—first to reach EFSA’s final review stage (approval expected 2025). Read more. Meet More Innovations with LipoAvail™ liposomal technology Explore Effepharm’s full portfolio in nutrition with unmatched absorption, including: LipoAvail™ Iron: 10mg/mL liquid concentration (5–10x industry standard) with 4x better absorption. LipoAvail™ Glutathione: 13x higher antioxidant delivery, bypassing stomach acid. LipoAvail™ Vitamin C: 7.86x enhanced uptake for immune and skin support. More at Effepharm’s Booth? Expert Insights: Engage with Dr. Yu Jianjun (R&D Director) and Dr. Rubén…

Traditional iron supplements often come with a nasty metallic aftertaste and digestive discomfort. But with ​​LipoAvail™ Iron​​, you don’t have to settle for “better than awful.” This breakthrough formula ditches the trade-offs, delivering both great taste and proven efficacy—without the gut irritation. No more choosing between tolerating a supplement and actually enjoying its benefits. Read the following to learn more.

UTHEVER® NMN is now the first NMN product to have finished the EU NOVEL FOOD public consultation phase (February 2025), bringing it the first to reach the EFSA’s risk assessment. Approval is currently pending, marking us as the fastest in the EU compliance race among all applicants.

2024: A Year of Exciting Milestones! 🎉 UthPeak™: The First NMNH with Self-GRAS Status 🎯 LipoAvail™ Liposomes Now with SC Certificate 🏅 Exciting Collaboration with Shanghai Jiao Tong University 🏫 NMN White Paper Published 📚 Founded Our Scientific Advisory Board: A group of global experts is now guiding us to even greater heights 🌍 A Fresh New Look for EffePharm ✨ ErgoX™ Ergothioneine for Personal Care 🌿 ...... Let's make 2025 another year of amazing things!

A Breakthrough Ingredient for Skincare EffePharm's ErgoX™ ergothioneine has recently achieved a major milestone by completing its registration as a cosmetic ingredient and obtaining its official registration code. This accomplishment highlights EffePharm's growing influence in the anti-aging and skincare industry. As a multifunctional ingredient in cosmetics, ErgoX™ offers antioxidant, whitening, and sunscreen properties, bringing a refreshing skincare experience to beauty enthusiasts. The Science Behind Ergothioneine Ergothioneine is a remarkable natural compound that has already gained recognition in the oral supplement market. Certified as a novel food in the European Union, it is celebrated for its mitochondrial-level anti-aging benefits, earning the trust of health-conscious consumers. With the rising demand for anti-aging solutions, ergothioneine has become a sought-after ingredient in skincare. Its ability to penetrate deeply into the skin allows it to neutralize free radicals, slow the aging process, brighten the complexion, and strengthen the skin barrier, enabling a youthful and radiant appearance. Advancing with EffeBio R&D Center The successful registration of ErgoX™ strengthens EffePharm's position in the anti-aging and skincare market while showcasing the cutting-edge capabilities of its EffeBio Biological Laboratory. This innovation hub is staffed by top-tier talent from prestigious institutions such as Shanghai Jiao Tong University, East China University…

We are thrilled to unveil the brand-new website! Get ready to dive into a vibrant world where innovation meets lifestyle. What’s New? 1. Fresh Look: Our sleek and modern redesigned site showcases our commitment to cutting-edge technology and a vibrant lifestyle. 2. Exciting Content: Our IDS platform has been rebranded as the Effe-PLUS platform! Explore our revamped sections—Home, Our Products, Effe-PLUS Platform, About Us, and Latest Updates—all designed for easy navigation. 3. Explore Our Expertise: Discover our business areas: Healthy Aging, Human Nutrition, Personal Care, and Effe-PLUS Platform. Everything you need is just a click away! 4. Knowledge at Your Fingertips: Explore our latest NMN White Paper on the homepage, and stay tuned as we continuously update our site with fresh market insights! 5. Search Made Easy: Our handy search tool means you can find exactly what you’re looking for in seconds! Join us on this exciting journey as we connect you with the best in health and wellness! Explore the new EffePharm today!

At SupplySide West 2024 in Las Vegas, the EffePharm team presented its groundbreaking LipoAvail™ liposome technology and innovative products designed to improve nutrient absorption and efficacy. These innovations underscore EffePharm’s commitment to advancing health solutions that address common challenges in the dietary supplement industry, with a particular focus on anti-aging and wellness. LipoAvail™ Liposomal Technology: Advancing Nutrient Delivery LipoAvail™ liposome technology is designed to overcome the widespread challenges in nutrient delivery. Active ingredients often face stability issues and poor absorption rates. This technology ensures better stability and improved bioavailability by encapsulating nutrients within protective lipid layers. For instance, NAD+—a crucial coenzyme for energy production and anti-aging—has traditionally been difficult to absorb effectively. LipoAvail™ technology improves its absorption by up to ninefold in the liver. Additionally, glutathione, an important antioxidant, benefits from an absorption boost of up to 13 times, enhancing its ability to support detoxification and cellular defense mechanisms. UthPeak™ NMNH: The Next-Generation NAD+ Enhancer One of EffePharm's key innovations is UthPeak™ NMNH. UthPeak™ NMNH is a form of reduced NMN (Nicotinamide Mononucleotide), serving as a direct precursor to NAD+, a crucial coenzyme for cellular energy production and longevity. This advanced formula has been shown to boost NAD+ levels by…

As the industry awaits a final decision on NMN’s regulatory status and the FDA’s response to the ongoing petition, one thing remains clear: NMN’s safety and effectiveness have been consistently demonstrated through years of use in the dietary supplement market.

Your Product Innovation Begins Here! SupplySide West is around the corner, and we're thrilled to give you a peek at our showcase: 📌 UthPeak™ NMNH: World’s first self-GRAS approved NMNH (reduced NMN) 📌 LipoAvail™ Liposomal Technology: Science-validated liposomal technology to increase bioavailability. Visit 📍 booth 4055 to discover how we can elevate your product offerings. Schedule a meeting with our team and be part of the innovation wave!

Dr. Zapata's research group specializes in developing novel therapies using both classical and innovative NAD+ enhancers, combined with other bioactive compounds, for in vitro and in vivo models of inherited or acquired mitochondrial diseases. Through this strategic partnership, EffePharm aims to reinforce its leadership in NAD+ research and deepen its commitment to providing clients with scientifically backed solutions for enhanced wellness and anti-aging benefits.

–EffePharm Announces Self-GRAS for Its New NAD+ Booster, UthPeak™ NMNH– SHANGHAI, China, Sept. 05, 2024 – EffePharm has announced that its proprietary UthPeak™ NMNH (reduced NMN) has achieved self-affirmed GRAS (generally recognized as safe) status following a recent review by an independent panel of qualified scientific and toxicology experts. In accordance with Food and Drug Administration (FDA) requirements, the panel agreed that the data demonstrate UthPeak™ NMNH can be sold, used, and consumed in the U.S. food supply. UthPeak™, marketed as "The Next-Gen Super NAD+ Enhancer," is a patent-pending crystalline NMNH that has demonstrated a remarkable 10X surge in NAD+ levels. UthPeak™ is believed to be the first NMNH brand to receive self-affirmed GRAS as a new generation NAD+ precursor. "The self-affirmed GRAS status is a testament to the safety and innovation of UthPeak™ NMNH and marks an essential step on our path toward commercialization," said Dr. Jianjun YU, EffePharm’s R&D Director. "At EffePharm, our business philosophy is rooted in delivering unique market value backed by scientific evidence. From our patent-protected crystalline form to extensive clinical studies, we believe UthPeak™ NMNH will provide distinct competitive advantages, enriching our clients' product offerings and enhancing their brand value. UthPeak™ Preclinical and Clinical…